                               NIH Public Access
                               Author Manuscript
                               Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                           Published final edited form 
NIH-PA Author Manuscript




                            Mol Biochem Parasitol. 2007 December ; 156(2): 246â€“254. doi:10.1016/j.molbiopara.2007.09.001.



                           Evidence capping enzyme specificity                            trypanosome spliced leader RNA

                           Jia-peng Ruana, Shuiyuan Shenb, Elisabetta Ullub,c, Christian Tschudia,b,*
                           Department Epidemiology & Public Health, Yale University Medical School, 295 Congress Avenue, New

                           Haven, CT 06536-0812, USA
                           bDepartment Internal Medicine, Yale University Medical School, 295 Congress Avenue, New Haven, CT
                           06536-0812, USA
                           cDepartment Cell Biology, Yale University Medical School, 295 Congress Avenue, New Haven, CT
                           06536-0812, USA

                           Abstract
NIH-PA Author Manuscript




                                 Capping pre-mRNA 5â€² end addition monomethylated guanosine cap (m7G) essential
                                 earliest modification biogenesis mRNA. reaction catalyzed enzymes:
                                 triphosphatase, guanylyltransferase, (guanine N-7) methyltransferase. modification
                                 occurs transcriptionally eukaryotic organisms, trypanosomatid protozoa mRNAs acquire
                                 m7G cap trans-splicing, entails transfer capped spliced leader (SL)                                  SL RNA mRNA. Intriguingly, genomes trypanosomatid protozoa sequenced date
                                 possess distinct proteins signature motifs guanylyltransferases: TbCGM1                                  previously characterized TbCE1. provide biochemical evidence TbCgm1 capping
                                 enzyme. RNAi-induced downregulation TbCe1 phenotypic consequences,                                  TbCGM1 essential trypanosome viability required SL RNA capping.
                                 Furthermore, consistent transcriptional addition m7G cap, chromatin
                                 immunoprecipitation revealed recruitment TbCgm1 SL RNA genes.


                           Keywords
                                 mRNA capping; guanylyltransferase; cap 4 modification; trans-splicing; SL RNA; RNAi
NIH-PA Author Manuscript




                           1. Introduction
                                              eukaryotic cells analyzed far, including Trypanosoma brucei, addition m7G cap
                                              represents earliest event modification 5â€² end RNA polymerase II (pol II)
                                              transcripts [1â€“3]. Capping occurs transcriptionally RNA achieved chain
                                              length 30 nucleotides (nt). Formation m7GpppN cap entails enzymatic
                                              reactions [4]. 5â€² triphosphate end hydrolyzed RNA 5â€² triphosphatase 5â€²
                                              diphosphate, capped GMP RNA guanylyltransferase. Finally,                                               guanosine moiety GpppN cap methylated RNA (guanine-N7) methyltransferase.
                                              cap-forming activities essential budding yeast [5â€“7].


                           *Corresponding author: Tel.: +1-203-7857332; Fax +1-203-7857329; E-mail address: E-mail: christian.tschudi@yale.edu.
                           Publisher's Disclaimer: PDF file unedited manuscript accepted publication. service customers
                           providing early version manuscript. manuscript undergo copyediting, typesetting, review resulting
                           proof published final citable form. note production process errors discovered                            affect content, legal disclaimers apply journal pertain.
                            Ruan et al.                                                                                               Page 2


                                         eukaryotes depend enzymatic reactions m7G capping,                                          physical organization capping apparatus quite diverse different organisms [4,8,9].
                                         component capping enzyme consisting bifunctional triphosphatase-
NIH-PA Author Manuscript




                                         guanylyltransferase polypeptide separate methyltransferase polypeptide present                                          metazoans plants. contrast, fungi microsporidia Encephalitozoon cuniculi                                          component separate triphosphatase, guanylyltransferase                                          methyltransferase polypeptides. protozoa Plasmodium falciparum [10] Giardia
                                         lamblia [11] yeast-like machinery. Extensive mutational analysis crystal structures
                                         revealed RNA guanylyltransferases related DNA RNA ligases [4,8,9]                                          structurally mechanistically conserved eukaryotic species viruses.
                                         Guanylyltransferases catalyze nucleotidyl transfer covalent enzyme-(lysyl-N)-
                                         GMP intermediate defined set conserved signature motifs [12].                                          hand, RNA triphosphatases fall mechanistically structurally distinct
                                         families. Triphosphatases fungi, microsporidia, protozoa, including T. brucei,                                          Chlorella virus belong family metal-dependant NTP phosphohydrolases defined                                          unique active site tunnel architecture [13,14], metazoan plant triphosphatases
                                         cysteine phosphatase superfamily [15,16]. crystal structure (guanine-
                                         N7) methyltransferase E. cuniculi highlighted known biochemical specificity                                          enzyme [17] completed catalogue protein structures enzymes required
                                         m7GpppN cap formation.
NIH-PA Author Manuscript




                                         eukaryotic organisms m7G capping restricted nascent pol II transcripts. contrast,
                                         studies trypanosomatid protozoa highlighted peculiar aspect mode cap
                                         formation, modification present pol II-transcribed spliced leader
                                         (SL) RNA, specific subset pol III transcripts, U1, U2,                                          U4 snRNAs U3 snoRNA. abundant pol III transcripts (tRNAs, 5S rRNA
                                         7SL RNA) capped, raises numerous questions specificity                                          regulation capping mechanism. Furthermore, mRNA cap addition occurs post-
                                         transcriptional trans-splicing, entails transfer 39-nt long SL sequence,
                                         including cap structure, SL RNA 5â€² end mRNAs [18â€“20]. SL
                                         RNA cap unique trypanosomatids contains hypermodified cap 4 structure,                                          derived methylation seven sites nucleotides SL RNA
                                         resulting structure: m7guanosine-ppp-N6,N6,2â€²-O-trimethyladenosine-p-2â€²-O-
                                         methyladenosine-p-2â€²-O-methylcytosine-p-N3,2â€²-O-methyluridine [21]. Recently, 2â€²-O-
                                         methyltransferases required cap 4 biogenesis identified shown                                          intriguingly similar vaccinia virus VP39 [22â€“25]. addition, cap 4 structure T.
                                         brucei specifically recognized unusual nuclear cap binding complex contains                                          novel essential subunits present trypanosomatids [26]. Taken                                          observations underscore uniqueness capping apparatus trypanosomatid protozoa.
NIH-PA Author Manuscript




                                         initial characterization enzymatic machinery involved m7G capping                                          trypanosomatids identified polypeptide Crithidia fasciculata T. brucei (Ce1)                                          structural biochemical properties characteristic GTP:RNA guanylyltransferases [27].
                                         carboxy-terminal half Ce1 displays signature motifs characteristic                                          guanylyltransferases, amino-terminal half contains domain unknown function                                          resemblance domain associated capping enzymes. course                                          studies, noted second polypeptide C. fasciculata T. brucei extracts approximately
                                         116 kDa, capable forming covalent protein-GMP complex, indicative capping
                                         enzyme.  characterization polypeptide pursued                                           recently, RNA triphosphatase (TbCet1) characterized T. brucei, structurally
                                         mechanistically related fungal metal-dependent phosphohydrolases [28],                                          recombinant T. brucei Cmt1 shown (guanine-N7) methyltransferase [29].                                          addition, data-base mining identified second candidate T. brucei capping enzyme, TbCgm1,


                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                            Page 3


                                          predicted N-terminal guanylyltransferase domain C-terminal methyltransferase
                                          domain [29]. manuscript preparation, Ho laboratory reported                                           TbCgm1 caps SL RNA [30].
NIH-PA Author Manuscript




                                           used RNA interference-induced regulation, biochemical properties                                           chromatin immunoprecipitation examine vivo function T. brucei capping
                                          enzymes TbCe1 TbCgm1 interface unusual capping pol II
                                          pol III transcripts.

                              2. Materials methods
                              2.1. Plasmids, transfections RNAi
                                          PCR products encompassing nt 1 - 894 N-terminal domain TbCE1, nt 180 - 1,180
                                          guanylyltransferase domain TbCGM1 inserted sense antisense
                                          orientation separated stuffer fragment plasmid pLEW100 [31] transfected                                           procyclic T. brucei strain 29.13.6 [32], harbors integrated genes T7 RNA
                                          polymerase tetracycline repressor. cells selected phleomycin cloned
                                          96 plates. Clonal cell lines induced adding tetracycline concentration                                           10 Î¼g/ml. PCR-based approach [33] used introduce BB2 epitope tag N-
                                          terminus TbCe1 TbCgm1 replace second allele blasticidin (BSR)
                                          resistant gene.
NIH-PA Author Manuscript




                                          produce recombinant guanylyltransferase E. coli, nt 1- 2,355 TbCGM1, corresponding
                                          amino acids 1 - 785, cloned NotI XhoI restriction sites T7
                                          RNA polymerase-based expression vector pET-44a (Novagen). lysine residue motif                                           changed alanine step PCR procedure mutation verified DNA
                                          sequencing.

                              2.2. RNA analysis
                                          RNA extraction Northern blot analysis performed described [34]. Figure 3B,
                                          4B 4C, SL RNA primer extended oligonucleotide Y-21, complementary                                           nt 40 60, Figure 4D SLIN22, complementary nt 110 131, used. U2, U3                                           U6 snRNAs primed oligonucleotide U2B-17, complementary nt 46 62, U3-PE,
                                          complementary nt 96 123, U6-22, complementary nt 19 40, respectively.

                                          Total RNA subjected immunoprecipitations rabbit polyclonal antibodies                                           m7G cap  kind gift Dr. F. Richards) mouse monoclonal antibodies                                           2,2,7-trimethylguanosine cap (Calbiochem). RNA samples analyzed primer extension.
NIH-PA Author Manuscript




                                          Uninduced TbCGM1 RNAi-induced procyclic T. brucei cells permeabilized                                           lysolecithin (L-Î±-lysophosphatidylcholine, palmitoyl, Sigma) RNA synthesized                                           15 minutes presence [Î±-32P]GTP [Î±-32P]ATP described [3,35,36]. Total RNA,
                                          extracted TRIZOL reagent, separated 6  polyacrylamide - 7M urea gels, SL
                                          RNA excised eluted water. Tobacco acid pyrophosphatase (TAP) cleavage                                           nuclease P1 digestion essentially described [3] digestion products                                           chromatographed Avicel cellulose layer plates, developed isobutyric acid/
                                          concentrated NH4OH/H2O, 66:1:33 (v/v/v).

                              2.3. procedures
                                          GMP binding [27] ChIP previously described [37].




                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                                Page 4


                              3. Results
                              3.1. guanylyltransferase domain TbCgm1 binds GMP
NIH-PA Author Manuscript




                                           search T. brucei databases additional components capping machinery,
                                           [29] predicted protein, TbCgm1, 116,820 Da (GeneDB accession #
                                           Tb927.7.2080) convincing homologies RNA (guanine-N7) methyltransferases                                            C-terminal half protein. domain motif searches revealed N-terminal
                                           half characteristics guanylyltransferase domain peptide motifs                                            absolutely conserved superfamily capping enzymes DNA ligases constitute
                                           active site GMP binding nucleotidyl transfer [4,29]. Northern blot, 5â€² end RACE
                                           sequencing cDNA clones established authenticity gene T. brucei
                                           genome determined structure mRNA 5â€² end (data shown).

                                           identification second putative guanylyltransferase domain eukaryotic organism
                                           unique.  finding rationalized earlier observation T. brucei
                                           cell extracts polypeptides 67 116 kDa capable forming covalent
                                           GMP-enzyme complex characteristic capping enzymes [27]. 67 kDa-
                                           polypeptide (TbCe1) shown functional guanylyltransferase domain, larger
                                           polypeptide pursued  view predicted molecular weight 117 kDa                                            presence putative N-terminal guanylyltransferase domain, TbCgm1 likely
                                           candidate second GMP-binding enzyme. test TbCGM1 encoded protein
NIH-PA Author Manuscript




                                           bind GMP covalent fashion, initially expressed length TbCgm1                                            Escherichia coli different expression vectors, did result                                            production sufficient quantities recombinant protein soluble form perform
                                           enzymatic tests.  generated construct containing 785 amino acids TbCgm1
                                           fused N-terminus E. coli NusA protein. 142 kDa protein corresponding                                            fusion protein detectable SDS-PAGE soluble extracts IPTG-induced bacteria
                                           (upper panel Fig. 1, lane 2). recombinant protein formed SDS-stable nucleotide-
                                           protein adduct (lower panel Fig. 1, lane 2), evident sample expressing
                                           NusA protein (lane 1). Importantly, protein lost ability bind GMP,                                            predicted catalytic lysine residue (amino acid 127) motif mutated alanine (lane 3),
                                           providing evidence TbCgm1 functional guanylyltransferase domain.

                              3.2. TbCgm1 encoded essential gene
                                           begin investigate vivo function T. brucei polypeptides containing
                                           guanylyltransferase domains, used RNA interference (RNAi) downregulate                                            respective mRNAs.  nt 1 - 894 TbCE1 nt 180 - 1,180 TbCGM1                                            inserted sense antisense orientation separated spacer fragment plasmid
NIH-PA Author Manuscript




                                           pLEW100 [38]. cassette, driven tetracycline (tet) inducible ribosomal promoter,                                            stably integrated non-transcribed rDNA spacer region clonal cell lines                                            established. RNAi induction tet, production double-stranded RNA                                            degradation target mRNA verified Northern blot (data shown). addition,
                                           extracts prepared CE1-RNAi cell lines induced 24 hr GMP-enzyme complex
                                           formation reduced undetectable levels (Fig. 2A), CGM1-RNAi cell lines                                            Cgm1 protein severely decreased, albeit detectable 24 hr (Fig. 2B). Importantly,
                                           results Figures 2A B demonstrated specificity downregulation Ce1                                            Cgm1 corresponding RNAi construct.  monitored cell growth period                                            4 days (Fig. 2C). Compared wild-type uninduced cells, downregulation TbCE1                                            noticeable effect cell viability. fact, maintaining induction 10 days did
                                           reveal detectable change growth characteristics. contrast, monitoring cell growth
                                           TbCGM1 RNAi induction revealed growth rate declined day 2 day
                                           3 eventually cells died (Fig. 2C), indicating TbCGM1 essential viability.


                                             Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                              Page 5


                              3.3. Depletion TbCE1 TbCGM1 does affect capping U2 snRNA U3 snoRNA
                                          Similar eukaryotes, trypanosomatid U1, U2 U4 snRNAs U3 snoRNA
                                          contain 2,2,7-trimethylguanosine (TMG) cap [39â€“41]. Little known sequence NIH-PA Author Manuscript




                                          events leading TMG cap trypanosomatids, presumed RNA molecules
                                          initially modified m7G cap [42,43].  set experiments, asked
                                          TbCE1 TbCGM1 downregulation effect cap formation U2 snRNA
                                          U3 snoRNA. TbCE1-RNAi cells induced tet 8 days, RNA prepared
                                          assayed immunoprecipitation anti-m7G anti-TMG antibodies followed                                           primer extension analysis (Fig. 3A). expected, U2 U3 RNAs affinity selected
                                          anti-TMG antibodies RNA prepared uninduced cells (Fig. 3A, lane 5),                                           RNAs detectable anti-m7G immunoprecipitate (lane 3). similar result
                                          obtained RNA isolated TbCE1-RNAi cells induced 8 days (lanes 8 10).
                                          Furthermore, detectable difference uninduced TbCGM1-RNAi cells                                           cells induced 2.5 days (Fig. 4A, compare lanes 2 5 lanes 7 10), indicating                                           cap formation U2 snRNA U3 snoRNA appeared normal conditions                                           TbCe1 TbCgm1 protein amounts limiting.

                              3.4. TbCgm1 involved SL RNA capping
                                          investigated RNAi-induced downregulation TbCE1 TbCGM1 affected
                                          cap formation pol II-transcribed SL RNA. RNA prepared TbCE1-RNAi cells
NIH-PA Author Manuscript




                                          induced 2.5 8 days assayed primer extension analysis SL RNA (Fig. 3B).
                                          shown previously [22,44] evident Figure 3B (lane 2), primer extension analysis                                           low deoxyribonucleotide triphosphate concentrations gives rise characteristic primer
                                          extension stop 5â€² end SL RNA indicative fully-methylated cap 4 structure
                                          (indicated fm SL). contrast, hypomethylated SL RNA (hm SL) prepared cells grown
                                          presence methylation inhibitor sinefungin, gives rise series bands
                                          characteristic SL RNA partially methylated cap 4 (Fig. 3B, lane 1). TbCE1
                                          downregulation 8 days did affect accumulation methylation status SL RNA,
                                          assayed primer extension analysis (Fig. 3B, compare lanes 2 4). contrast, following
                                          2 2.5 days induction TbCGM1 RNAi, accumulation SL RNA reduced
                                          76  36 , respectively, compared uninduced cells (Fig. 4B). addition, clear
                                          defect cap 4 formation evident fully-modified SL RNA reduced 34  13 
                                          day 2 2.5, respectively, concomitant appearance longer extension products
                                          indicative SL RNA carrying hypomethylated cap 4 (lanes 4 5).

                                          address apparent effect TbCGM1 downregulation SL RNA cap formation                                            used immunoprecipitation anti-m7G antibodies (Fig. 4C).                                           majority fully-modified SL RNA affinity selected RNA isolated NIH-PA Author Manuscript




                                          uninduced cells (lane 3), 2.5 days induction hypomethylated SL RNA                                           predominantly supernatant (compare lanes 5 6). contrast, small                                           fully-modified SL RNA present 2.5 days induction immunoprecipitated                                           anti-m7G antibodies (lane 6).  epitope recognized antibody present                                           considerable proportion steady-state SL RNA accumulating downregulation                                           Cgm1, suggesting defect m7G cap.

                                           turned analysis newly-synthesized RNA permeabilized T. brucei cells.
                                          Uninduced TbCGM1-RNAi cells induced 1 2.5 days permeabilized                                           lysolecithin incubated 15 min transcription cocktail containing [Î±-32P]GTP [35].
                                          Using number cells permeabilization procedure, obvious
                                          difference total RNA synthesis induced cells, compared uninduced cells (data
                                          shown). SL RNA gel purified digested tobacco acid pyrophosphatase
                                          (TAP), released cap nucleotide SL RNA hydrolyzing pyrophosphate


                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                               Page 6


                                          bond. digestion products separated layer chromatography (TLC) analyzed
                                          phosphorimaging (Fig. 5A). treatment released 1.5  radioactive label SL
                                          RNA uninduced cells form m7G (lane 1). value did change 1 day
NIH-PA Author Manuscript




                                          TbCGM1 depletion (lane 2, 1.5 ), reduced 0.8  following 2.5 days induction
                                          (lane 3). uninduced (lane 1) 1 day-induced cells (lane 2) 0.8  radioactive label
                                          released TAP form GMP, indicative cap methyl group                                           N7 position guanosine. value increased 1.4  sample isolated cells
                                          induced 2.5 days (lane 3). addition, new spot (1.5  radioactive label)
                                          did correspond available standards (labeled X1 Fig. 5A). 
                                          dimensional TLC analysis (data shown) failed clues possible nature                                           X1 spot.  data agreement immunoprecipitation results
                                          anti-m7G antibodies indicated CGM1 silencing increase
                                          proportion SL RNA bearing unmethylated cap structure.

                                          define consequences TbCgm1 depletion SL RNA cap, permeabilized
                                          cells labeled [Î±-32P]ATP order monitor status adenosine position
                                          1, e. initiating nucleotide, SL RNA. gel purified SL RNA digested                                           nuclease P1 (Fig. 5B) generates 5â€²nucleotide monophosphates, does cleave
                                          pyrophosphate bonds, e. cleave triphosphate bridge linking m7G                                           adenosine position 1. expected, sample prepared uninduced cells majority
                                          label (96 ) comigrated AMP (lane 1). prominent spot (3 , designated
NIH-PA Author Manuscript




                                          X2) did correspond available standards, decreased induction
                                          period 50  abundant 2.5 days. P1 digestion SL RNA labeled                                           [Î±-32P]GTP generated identical spot (data shown) speculate                                           represents dinucleotide derived cap structure. addition, 0.7  radioactive
                                          label associated ATP, likely originates 5â€² end primary SL
                                          transcripts. Following 1 2.5 days TbCgm1 depletion level ATP did change
                                          significantly. fourth spot identified ADP. SL RNA uninduced cells
                                          0.2  radioactivity associated ADP, downregulation TbCGM1 1 2.5
                                          days resulted gradual increase ADP reaching 0.5  2.5 days. likely
                                          explanation result TbCgm1 depletion gave rise increase diphosphate-
                                          terminated RNA, e. capping transcripts blocked triphosphatase step,
                                          removed terminal phosphate primary transcript.  taken                                           observations provided supporting evidence TbCgm1 required capping SL
                                          RNA.

                              3.5. Trans-splicing utilization SL RNA reduced TbCgm1-depleted cells
                                          m7G cap determinants utilization SL RNA trans-
                                          splicing, examined trans-splicing activity TbCgm1-depleted cells (Fig. 4D). RNA
NIH-PA Author Manuscript




                                          derived uninduced cells (lane 2), primer extension analysis produced cDNA
                                          corresponding length SL RNA, primer extension stop mapping 5â€² end
                                          SL intron, diagnostic Y-structures (SL RNA intron-pre-mRNA
                                          branched intermediates formed step trans-splicing). Y-structures                                           detectable cells treated sinefungin (lane 1), drug blocks trans-splicing                                           trypanosomes [45]. analysis TbCGM1 silencing reduced                                           accumulation Y-structures 35  2.5 days induction (Fig. 4D, lane 5).

                              3.6. Recruitment TbCgm1 SL RNA genes
                                          provide independent evidence TbCgm1 involved maturation SL RNA,
                                          monitored vivo association polypeptide SL RNA genes using
                                          chromatin immunoprecipitation (ChIP). end, generated T. brucei cell line
                                          expressing solely epitope-tagged version TbCgm1. deleted allele homologous


                                            Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                                Page 7


                                         recombination PCR-generated cassette encoding blasticidin resistance gene                                          introduced N-terminal BB2 epitope second allele original chromosomal locus.
                                         approach ensured epitope-tagged version protein functional NIH-PA Author Manuscript




                                         expressed levels comparable endogenous protein. addition, generated cell line
                                         solely expressing BB2 epitope-tagged TbCe1. previously shown ChIP pol II
                                         transcription factor TRF4 recruited SL RNA genes [37]. Using                                          protocol, TbCgm1 specifically associated SL RNA genes (Fig. 6, lane 6),
                                         upstream control region (lane 3). contrast, did detect recruitment                                          TbCe1 SL RNA genes (lane 12). result corroborated RNAi permeable cell
                                         experiments supported conclusion TbCgm1 plays role capping                                          SL RNA.

                              4. Discussion
                                         Eukaryotes rely enzymatic reactions formation m7GpppN cap,                                          sequential action RNA 5â€² triphosphatase, RNA guanylyltransferase RNA (guanine-
                                         N7) methyltransferase. physical organization capping apparatus quite
                                         distinct different taxa [4,8,9], enzymatic activity assigned single polypeptide
                                         domain. contrast, distinct novel genetic organization emerging                                          trypanosomatids, presence guanylyltransferase domains: (TbCe1) fused
                                         N-terminal domain unknown function [27] second (TbCgm1) C-terminal
NIH-PA Author Manuscript




                                         (guanine-N7) methyltransferase [29,30]. addition, separate RNA triphosphatase,
                                         mechanistically related fungal enzymes [28,46], separate (guanine-N7)
                                         methyltransferase [29]. polypeptides characterized
                                         biochemically shown involved m7G capping, challenge remains assign                                          vivo functions. taken step goal analyzed functional
                                         consequences TbCe1 TbCgm1 downregulation. Surprisingly, RNAi downregulation                                          Ce1 phenotypic consequences, precluding investigations route.
                                          interpret result mean TbCe1 needed capping                                          trypanosomes. RNAi does generate â€œknockoutâ€?, downregulates mRNA
                                         levels, likely explanation residual TbCe1 protein sufficient
                                         cell growth.  far able generate â€œclassicalâ€? TbCE1 knockout
                                         strain, alleles gene replaced antibiotic resistance marker,
                                         indicating gene likely essential.  vivo function TbCe1
                                         remains determined.

                                         shown presence diagnostic motifs [29] mutagenesis analysis, TbCgm1
                                         hallmarks activity RNA guanylyltransferase. contrast negative
                                         results obtained RNAi downregulation CE1, silencing CGM1 severe
NIH-PA Author Manuscript




                                         consequences cell viability SL RNA capping: 2 3 days RNAi
                                         induction cells stopped growing demonstrating Cgm1 function essential cell
                                         viability. result similar observed yeast S. cerevisiae,                                          originally shown Ceg1, gene encoding capping enzyme, essential [7].                                          time interval cell growth begins slow  observed anomalies                                          regard SL RNA.  steady-state level SL RNA decreased substantially.                                          effect instability SL RNA molecules unmethylated cap
                                         result inhibition trans-splicing, likely cause havoc                                          cells. Second, accumulation molecules bearing hypomodified cap 4 structure.
                                         explanation finding likely lies requirement m7G cap                                          biogenesis cap 4 structure.  vaccinia virus steps biosynthesis                                          cap occur unique sequence, e. modification nucleotide adjacent cap
                                         requires m7G cap place [47].  CGM1 silencing proportion SL
                                         RNA bearing methylated cap substantially decreased, assessed antibody


                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                                               Page 8


                                         immunoprecipitation steady-state SL RNA TAP digestion newlyâ€“synthesized SL
                                         RNA. Lastly, P1 digestion TLC analysis showed accumulation newly-
                                         synthesized SL RNA molecules ADP terminus. summary, results showed NIH-PA Author Manuscript




                                         Cgm1 depletion results defects addition GMP methylation N7
                                         position guanine. basis analyses, propose guanylyltransferase
                                         domain TbCgm1 responsible adding GMP diphosphate terminated SL RNA.
                                         Activity assays recombinant protein corroborated proposed function domain.
                                         Furthermore, observation relative m7G cap decreased, consequence
                                         TbCgm1 depletion, concomitant increase unmethylated GMP cap, provides
                                         evidence polypeptide required methylation step capping reaction.
                                         far, able produce putative C-terminal (guanine-N7)
                                         methyltransferase domain recombinant form test proposed enzymatic activity.                                          manuscript preparation, Ho laboratory reported recombinant TbCgm1                                          bifunctional capping enzyme capable transferring GMP SL RNA covalent enzyme-
                                         GMP intermediate [30]. addition, shown TbCgm1 methylates guanine N-7
                                         position GpppN-terminated RNA. Taken  results agreement                                          TbCgm1 responsible capping SL RNA.

                                         previously shown SL RNA transcripts short 30 nucleotides capped,
                                         consistent transcriptional mechanism m7G capping addition [3]. model                                          strengthened ChIP experiments presented  revealed vivo
NIH-PA Author Manuscript




                                         association TbCgm1 SL RNA genes. remains explored                                          capping enzyme recruited transcriptional machinery. SL RNA genes                                          transcribed pol II [48], mechanism likely similar described yeast                                          mammals, physical interaction capping enzyme CTD                                          largest subunit pol II [49,50].

                                         presence guanylyltransferase domains trypanosomatid protozoa unexpected
                                         far, best knowledge, reported eukaryotic organism.
                                         important bear mind capping organisms occurs pol II
                                         transcripts, SL RNA, specific subset pol III transcripts.                                          attractive possibility TbCe1 involved capping subset pol III transcripts.                                          TbCe1 directed U1, U2, U3 U4 snRNAs, abundant
                                         pol III transcripts, present matter speculation. pol III common                                          genes, possibilities consider specificity achieved gene-
                                         specific transcription factor(s), RNA determinants combination mechanisms.

                              Acknowledgments
NIH-PA Author Manuscript




                                         thank Andrei Alexandrov help discussion TLC analysis. study received support National
                                         Institutes Health Grant AI43594 C.T.


                              References
                                         1. Rasmussen EB, Lis JT. vivo transcriptional pausing cap formation Drosophila heat
                                            shock genes. Proc Natl Acad Sci U S 1993;90:7923â€“7. [PubMed: 8367444]
                                         2. Hagler J, Shuman S. freeze-frame view eukaryotic transcription elongation capping
                                            nascent mRNA. Science 1992;255:983â€“6. [PubMed: 1546295]
                                         3. Mair G, Ullu E, Tschudi C. Cotranscriptional cap 4 formation Trypanosoma brucei spliced
                                            leader RNA. J Biol Chem 2000;275:28994â€“9. [PubMed: 10880518]
                                         4. Shuman S. Structure, mechanism, evolution mRNA capping apparatus. Prog Nucleic Acid
                                            Res Mol Biol 2001;66:1â€“40. [PubMed: 11051760]




                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                                    Page 9


                                         5. Shibagaki Y, Itoh N, Yamada H, Nagata S, Mizumoto K. mRNA capping enzyme. Isolation                                             characterization gene encoding mRNA guanylytransferase subunit Saccharomyces
                                            cerevisiae. J Biol Chem 1992;267:9521â€“8. [PubMed: 1315757]
NIH-PA Author Manuscript




                                         6. Mao X, Schwer B, Shuman S. Yeast mRNA cap methyltransferase 50-kilodalton protein encoded
                                            essential gene. Mol Cell Biol 1995;15:4167â€“74. [PubMed: 7623811]
                                         7. Tsukamoto T, Shibagaki Y, Imajoh-Ohmi S, Murakoshi T, Suzuki M, Nakamura  Gotoh H,
                                            Mizumoto K. Isolation characterization yeast mRNA capping enzyme beta subunit gene
                                            encoding RNA 5â€²-triphosphatase, essential cell viability. Biochem Biophys Res Commun
                                            1997;239:116â€“22. [PubMed: 9345280]
                                         8. Shuman S. messenger RNA capping tells eukaryotic evolution. Nat Rev Mol Cell Biol
                                            2002;3:619â€“25. [PubMed: 12154373]
                                         9. Shuman S, Lima CD. polynucleotide ligase RNA capping enzyme superfamily covalent
                                            nucleotidyltransferases. Curr Opin Struct Biol 2004;14:757â€“64. [PubMed: 15582400]
                                         10. Ho CK, Shuman S. yeast-like mRNA capping apparatus Plasmodium falciparum. Proc Natl
                                             Acad Sci U S 2001;98:3050â€“5. [PubMed: 11248030]
                                         11. Hausmann S, Altura MA, Witmer M, Singer SM, Elmendorf HG, Shuman S. Yeast-like mRNA
                                             capping apparatus Giardia lamblia. J Biol Chem 2005;280:12077â€“86. [PubMed: 15556935]
                                         12. Hakansson K, Doherty AJ, Shuman S, Wigley DB. X-ray crystallography reveals large
                                             conformational change guanyl transfer mRNA capping enzymes. Cell 1997;89:545â€“53.
                                             [PubMed: 9160746]
                                         13. Lima CD, Wang LK, Shuman S. Structure mechanism yeast RNA triphosphatase: essential
NIH-PA Author Manuscript




                                             component mRNA capping apparatus. Cell 1999;99:533â€“43. [PubMed: 10589681]
                                         14. Gong C, Shuman S. Chlorella virus RNA triphosphatase: mutational analysis mechanism                                              inhibition tripolyphosphate. J Biol Chem 2002;13:13.
                                         15. Takagi T, Moore CR, Diehn F, Buratowski S. RNA 5â€²-triphosphatase related protein tyrosine
                                             phosphatases. Cell 1997;89:867â€“73. [PubMed: 9200605]
                                         16. Changela  Ho CK, Martins  Shuman S, Mondragon  Structure mechanism RNA
                                             triphosphatase component mammalian mRNA capping enzyme. EMBO J 2001;20:2575â€“86.
                                             [PubMed: 11350947]
                                         17. Fabrega C, Hausmann S, Shen V, Shuman S, Lima CD. Structure mechanism mRNA cap
                                             (guanine-N7) methyltransferase. Mol Cell 2004;13:77â€“89. [PubMed: 14731396]
                                         18. Murphy WJ, Watkins KP, Agabian N. Identification novel Y branch structure intermediate
                                             trypanosome mRNA processing: evidence trans splicing. Cell 1986;47:517â€“25. [PubMed:
                                             3779835]
                                         19. Sutton  Boothroyd JC. Evidence trans splicing trypanosomes. Cell 1986;47:527â€“35.
                                             [PubMed: 3022935]
                                         20. Laird PW, Zomerdijk JC, Korte D, Borst P. vivo labelling intermediates discontinuous
                                             synthesis mRNAs Trypanosoma brucei. EMBO J 1987;6:1055â€“62. [PubMed: 3595556]
                                         21. Bangs JD, Crain PF, Hashizume T, McCloskey JA, Boothroyd JC. Mass spectrometry mRNA cap
NIH-PA Author Manuscript




                                             4 trypanosomatids reveals novel nucleosides. J Biol Chem 1992;267:9805â€“15. [PubMed:
                                             1349605]
                                         22. Arhin GK, Li H, Ullu E, Tschudi C. protein related vaccinia virus cap-specific
                                             methyltransferase VP39 involved cap 4 modification Trypanosoma brucei. RNA 2006;12:53â€“
                                             62. [PubMed: 16301606]
                                         23. Arhin GK, Ullu E, Tschudi C. 2â€²-O-methylation position 2 trypanosome spliced leader cap
                                             4 mediated 48 kDa protein related vaccinia virus VP39. Mol Biochem Parasitol
                                             2006;147:137â€“9. [PubMed: 16516986]
                                         24. Zamudio JR, Mittra B, Zeiner GM, Feder M, Bujnicki JM, Sturm NR, Campbell DA. Complete cap
                                             4 formation required viability Trypanosoma brucei. Eukaryot Cell 2006;5:905â€“15.
                                             [PubMed: 16757738]
                                         25. Hall MP, Ho CK. Functional characterization 48 kDa Trypanosoma brucei cap 2 RNA
                                             methyltransferase. Nucleic Acids Res 2006;34:5594â€“602. [PubMed: 17028101]
                                         26. Li H, Tschudi C. Novel essential subunits 300-kilodalton nuclear cap binding complex                                              Trypanosoma brucei. Mol Cell Biol 2005;25:2216â€“26. [PubMed: 15743819]


                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                                   Page 10


                                         27. Silva E, Ullu E, Kobayashi R, Tschudi C. Trypanosome capping enzymes display novel domain
                                             structure. Mol Cell Biol 1998;18:4612â€“9. [PubMed: 9671471]
                                         28. Ho CK, Shuman S. Trypanosoma brucei RNA triphosphatase. Antiprotozoal drug target guide
NIH-PA Author Manuscript




                                             eukaryotic phylogeny. J Biol Chem 2001;276:46182â€“6. [PubMed: 11553645]
                                         29. Hall MP, Ho CK. Characterization Trypanosoma brucei RNA cap (guanine N-7)
                                             methyltransferase. RNA 2006;12:488â€“97. [PubMed: 16431985]
                                         30. Takagi Y, Sindkar S, Ekonomidis D, Hall MP, Ho CK. Trypanosoma brucei encodes bifunctional
                                             capping enzyme essential cap 4 formation spliced leader RNA. J Biol Chem
                                             2007;282:15995â€“6005. [PubMed: 17416901]
                                         31. Djikeng, ; Shen, S.; Tschudi, C.; Ullu, E. Analysis gene function Trypanosoma brucei using
                                             RNA interference.  Melville, S., editor. Parasite Genomics Protocols. Vol. 270. Humana Press
                                              2004. p. 287-97.
                                         32. Wirtz E, Leal S, Ochatt C, Cross GA. tightly regulated inducible expression conditional
                                             gene knock-outs dominant-negative genetics Trypanosoma brucei. Mol Biochem Parasitol
                                             1999;99:89â€“101. [PubMed: 10215027]
                                         33. Arhin GK, Shen S, Ullu E, Tschudi C. PCR-based method gene deletion protein tagging
                                             Trypanosoma brucei. Methods Mol Biol 2004;270:277â€“86. [PubMed: 15153634]
                                         34. Djikeng  Shi H, Tschudi C, Ullu E. RNA interference Trypanosoma brucei: cloning small
                                             interfering RNAs provides evidence retroposon-derived 24â€“26-nucleotide RNAs. RNA
                                             2001;7:1522â€“30. [PubMed: 11720282]
                                         35. Ullu E, Tschudi C. Permeable trypanosome cells model transcription trans-
NIH-PA Author Manuscript




                                             splicing. Nucleic Acids Res 1990;18:3319â€“26. [PubMed: 2356121]
                                         36. Ullu E, Tschudi C. Trans splicing trypanosomes requires methylation 5â€² end spliced
                                             leader RNA. Proc Natl Acad Sci U S 1991;88:10074â€“8. [PubMed: 1719544]
                                         37. Ruan JP, Arhin GK, Ullu E, Tschudi C. Functional characterization Trypanosoma brucei TATA-
                                             binding protein-related factor points universal regulator transcription trypanosomes. Mol
                                             Cell Biol 2004;24:9610â€“8. [PubMed: 15485927]
                                         38. Shi H, Djikeng  Mark T, Wirtz E, Tschudi C, Ullu E. Genetic interference Trypanosoma
                                             brucei heritable inducible double-stranded RNA. RNA 2000;6:1069â€“76. [PubMed:
                                             10917601]
                                         39. Djikeng  Ferreira L, Dâ€™Angelo M, Dolezal P, Lamb T, Murta S, Triggs V, Ulbert S, Villarino 
                                             Renzi SUE, Tschudi C. Characterization candidate Trypanosoma brucei U1 snRNA gene. Mol
                                             Biochem Parasitol 2001;113:91â€“7.
                                         40. Tschudi C, Richards FF, Ullu E. U2 RNA analogue Trypanosoma brucei gambiense:
                                             implications splicing mechanism trypanosomes. Nucleic Acids Res 1986;14:8893â€“903.
                                             [PubMed: 3786140]
                                         41. Mottram J, Perry KL, Lizardi PM, Luhrmann R, Agabian N, Nelson RG. Isolation sequence                                              small nuclear U RNA genes Trypanosoma brucei subsp. brucei: identification U2, U4,
                                             U6 RNA analogs. Mol Cell Biol 1989;9:1212â€“23. [PubMed: 2725495]
NIH-PA Author Manuscript




                                         42. Gunzl  Bindereif  Ullu E, Tschudi C. Determinants cap trimethylation U2 small nuclear
                                             RNA conserved Trypanosoma brucei higher eukaryotic organisms. Nucleic
                                             Acids Res 2000;28:3702â€“9. [PubMed: 11000261]
                                         43. Tschudi C, Ullu E. Unconventional rules small nuclear RNA transcription cap modification
                                             trypanosomatids. Gene Expr 2002;10:3â€“16. [PubMed: 11868986]
                                         44. Mandelboim M, Estrano CL, Tschudi C, Ullu E, Michaeli S. role exon intron sequences
                                             trans-splicing utilization cap 4 modification trypanosomatid Leptomonas collosoma SL
                                             RNA. J Biol Chem 2002;277:35210â€“8. [PubMed: 12121975]
                                         45. McNally KP, Agabian N. Trypanosoma brucei spliced-leader RNA methylations required                                              trans splicing vivo. Mol Cell Biol 1992;12:4844â€“51. [PubMed: 1406666]
                                         46. Gong C, Martins  Shuman S. Structure-function analysis Trypanosoma brucei RNA
                                             triphosphatase evidence metal mechanism. J Biol Chem 2003;278:50843â€“52.
                                             [PubMed: 14525979]
                                         47. Barbosa E, Moss B. mRNA(nucleoside-2â€²-)-methyltransferase vaccinia virus. Characteristics
                                             substrate specificity. J Biol Chem 1978;253:7698â€“702. [PubMed: 701282]


                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                               Page 11


                                         48. Gilinger G, Bellofatto V. Trypanosome spliced leader RNA genes contain identified RNA
                                             polymerase II gene promoter organisms. Nucleic Acids Res 2001;29:1556â€“64. [PubMed:
                                             11266558]
NIH-PA Author Manuscript




                                         49. Cho EJ, Takagi T, Moore CR, Buratowski S. mRNA capping enzyme recruited transcription
                                             complex phosphorylation RNA polymerase II carboxy-terminal domain. Genes Dev
                                             1997;11:3319â€“26. [PubMed: 9407025]
                                         50. McCracken S, Fong N, Rosonina E, Yankulov K, Brothers G, Siderovski D, Hessel  Foster S,
                                             Program AE, Shuman S, Bentley DL. 5â€²-Capping enzymes targeted pre-mRNA binding                                              phosphorylated carboxy-terminal domain RNA polymerase II. Genes Dev 1997;11:3306â€“18.
                                             [PubMed: 9407024]
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                       Page 12
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Fig. 1.
                                         guanylyltransferase domain TbCgm1 binds GMP. Soluble protein lysates bacteria
                                         expressing NusA protein (pET-44, lane 1), amino acids 1 - 785 TbCgm1 fused NIH-PA Author Manuscript




                                         NusA protein (wt, lane 2), fusion protein indicated mutation (K127A, lane 3)
                                         fractionated SDS-PAGE stained Coomassie blue dye (upper panel) tested
                                         GMP binding (lower panel, autoradiograph shown). sizes  kilodaltons)                                          marker proteins shown right position NusA-TbCgm1 fusion proteins
                                         indicated arrow.




                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                         Page 13
NIH-PA Author Manuscript




                                         Fig. 2.
                                         RNAi-induced downregulation TbCE1 TbCGM1.   independent clonal cell lines
NIH-PA Author Manuscript




                                         expressing TbCE1 dsRNA grown absence (lanes 1 3) presence (lanes 2                                          4) 24 hr total cell extracts assayed enzyme-GMP complex formation. (B)                                          assay panel  , TbCGM1 downregulated (lanes 2 4). (C) Cell
                                         densities measured 24, 48, 72, 90 96 hr induction RNAi tetracycline                                          clonal cell line expressing double-stranded RNA TbCE1 TbCGM1.                                          growth curves uninduced cells essentially identical wild-type cells (wt),                                          represented 
NIH-PA Author Manuscript




                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                            Page 14
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Fig. 3.
                                         TbCE1 downregulation RNAi.   Total RNA isolated uninduced (lanes 1â€“5)                                          TbCE1-RNAi cells induced 8 days (lanes 6â€“10) immunoprecipitated anti-m7G
                                         anti-TMG antibodies input  , supernatant (S) pellet (P) fractions assayed
                                         primer extension U2 snRNA (U2) U3 snoRNA (U3). (B) TbCE1 RNAi cell
                                         line induced tet indicated number days (lanes 2â€“4) total RNA                                          assayed primer extension SL intron-specific primer. position fully-modified
                                         (fm SL) hypomodified (hm SL) SL RNA indicated. RNA isolated sinefungin-
                                         treated cells served control hypomodified SL RNA (lane 1). U6 snRNA-specific
                                         primer included reactions control RNA amounts quality.

                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                         Page 15
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Fig. 4.
                                         TbCGM1 depletion affects SL RNA capping.   Total RNA isolated uninduced (lanes
                                         1â€“5) TbGM1-RNAi cells induced 2.5 days (lanes 6â€“10) immunoprecipitated                                          anti-m7G anti-TMG antibodies input  , supernatant (S) pellet (P) fractions
NIH-PA Author Manuscript




                                         assayed primer extension U2 snRNA (U2) U3 snoRNA (U3). (B)                                          TbCGM1 RNAi cell line induced tet indicated number days (lanes 2â€“5)                                          total RNA assayed primer extension SL intron-specific primer. position
                                         fully-modified (fm SL) hypomodified (hm SL) SL RNA indicated. RNA isolated
                                         sinefungin-treated cells served control hypomodified SL RNA (lane 1). U6
                                         snRNA-specific primer included reactions control RNA amounts quality.
                                         (C) Total RNA isolated uninduced cells (lanes 1â€“3) cells depleted TbCgm1
                                         2.5 days (lanes 4â€“6) immunoprecipitated anti-m7G antibodies input  ,
                                         supernatant (S) pellet (P) fractions assayed primer extension SL intron-
                                         specific primer. U6-snRNA-specific primer included reactions control                                          immunoprecipitation specificity (U6). (D) Primer extension total RNA                                          oligonucleotide complementary nt 110 131 SL RNA. position Y-structure
                                         intermediate (Y) length SL RNA (SL) indicated. RNA isolated sinefungin-



                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                            Page 16


                                         treated cells used control trans-splicing inhibition (lane 1). oligonucleotide
                                         complementary U2 snRNA included loading quality control (U2).
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Mol Biochem Parasitol. Author manuscript; available PMC 2009 July 6.
                            Ruan et al.                                                                                          Page 17
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                         Fig. 5.
                                         Newly-synthesized RNA labeled [Î±-32P]GTP [Î±-32P]ATP prepared                                          permeabilized cells, spliced leader RNA gel purified analyzed tobacco acid
                                         pyrophosphatase P1 digestion. panels, SL RNA isolated uninduced
                                         cells (lane 1), cells depleted TbCGM1 1 day (lane 2) 2.5 days (lane 3).  
                                         cap nucleotide visualized digesting [Î±-32P]GTP-labeled SL RNA tobacco
                                         acid pyrophosphatase TLC separation. positions nonradioactive m7Gp Gp
                                         markers (visualized UV light) indicated. (B) [Î±-32P]ATP-label